Ashfield appoints President of Global Business Development

Mr Esgro assumes his position at Ashfield having most recently served as Vice President of Strategic Business Development US Commercial for Iqvia where he was responsible for business development efforts in the US

George Esgro

Ashfield, part of UDG Healthcare, a global leader in commercialisation services for the pharmaceutical and healthcare industry, is pleased to announce the appointment of George Esgro as President of Global Business Development for Ashfield Commercial and Patient Solutions.

Commenting on the appointment, Greg Flynn, Global Chief Operating Officer of Ashfield Commercial and Patient Solutions, said: “George brings with him a wealth of industry knowledge and expertise and I am delighted to welcome George to Ashfield."

“As we continue to grow our organisation globally, George will be an integral part of our journey. His drive, experience and passion will help us to continue to expand our organization and exceed our clients’ needs.”

A veteran of the pharmaceutical industry, Mr Esgro joined QuintilesIMS, now Iqvia, in 2009 as a senior director of commercial sales where he led projects through a team of national sales directors and project leads.

He provided strategies and oversight for all sales teams, while maintaining customer relationships to ensure project success. Mr Esgro then served as Vice President of Commercial Sales and later as Vice President of Global Business Development for Commercial North America.

Mr Esgro added: “I am excited to be joining Ashfield at such an exciting time for the organisation."

“Ashfield has grown significantly in recent years and its mission to be the partner of choice for healthcare companies outsourcing their Commercial, Patient Solutions and Medical Affairs programs globally, really resonates with me."

“Our focus will be on demonstrating the value our teams create for clients and providing high quality, innovative solutions."

Mr Esgro has also held sales, leadership, training, and marketing roles at various pharmaceutical companies, including 13 years with GlaxoSmithKline. George graduated with a Bachelor’s degree in business administration from James Madison University, and currently serves on their Business School Advisory Board.